Blog | Association for Accessible Medicines

Stop REMS Abuse - Anti-competitive practices are costing patients billions - you can help!

Blocking Patient Access - FDA-mandated Patient safety programs (REMS)

Jul 18, 2017 | Erica Klinger

Using Safety Programs to Protect Profits, Not Patients

2017 Generic Drug Access & Savings in the U.S.

Jun 8, 2017 | Erica Klinger

2017 Generic Drug Access and Savings in the U.S. Report

CMC Workshop

Apr 11, 2017 | Erica Klinger

Learn to manage the GDUFA landscape at our CMC Workshop

Pharmacy Patient

Apr 10, 2017 | Erica Klinger

Veto Maryland House Bill 631, Which Would Harm Patients by Chilling Generic Drug Competition

Chip Davis, President and CEO, Association for Accessible Medicines; Photo Courtesy of The Atlantic | AtlanticLIVE / Photo by Kevin Dietsch

Mar 28, 2017 | Erica Klinger

Recapping: The Future for Biosimilars

Experts Panel

Mar 10, 2017 | Erica Klinger

The Future of Biosimilars – An Atlantic Policy Briefing

2016 AAM Annual Report

Feb 8, 2017 | Erica Klinger

2016 AAM Annual Report